# US 2016/0251335 A1 · New compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0251335 A1
- Document ID: US20160251335A1
- Status: Published application
- Kind: A1
- Application number: 15/030,476
- Filed: 2014-11-14
- Published: 2016-09-01
- Earliest claimed: 2013-11-18
- Assignees: Elanco Tiergesundheit AG
- Inventors: Noëlle Gauvry; François Pautrat
- Web page: https://patentgrep.com/patent/US20160251335A1

## CPC

- A01N 43/80: five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
- A61P 33/00: Antiparasitic agents
- C07D 211/58: attached in position 4
- C07D 213/74: Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- C07D 213/81: Amides; Imides
- C07D 239/28: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D 239/42: One nitrogen atom (nitro radicals C07D239/30)
- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 401/10: linked by a carbon chain containing aromatic rings
- C07D 401/14: containing three or more hetero rings
- C07D 487/10: Spiro-condensed systems
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention relates to compounds of the general formula (I) wherein the variable have the meanings as indicated in the claims, or a physiologically acceptable salt thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling endoparasites in warm-blooded animals.

## Claims

### Claim 1

A compound of formula
wherein Z1 and Z2 are each independently N or CR1′;
R1 and R1′ are each independently of the other H, halogen, cyano, nitro, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C3-haloalkoxyl, C1-C4-alkylthio, halo-C1-C4-alkylthio, SF5, amino, N-mono- or N,N-di-C1-C4-alkylamino, aminosulfonyl, N-mono- or N,N-di-C1-C4-alkylaminosulfonyl, N-mono- or N,N-di-halo-C1-C4-alkylaminosulfonyl, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonylamino, halo-C1-C4-alkylsulfonyl, halo-C1-C4-alkylsulfinyl, halo-C1-C4-alkylsulfonylamino or benzylsulfonylamino;
Q is Ar1 or —C(O)—(O)m—R2;
m is 0 or 1; R2 is C1-C6-alkyl or C3-C8-cycloalkyl;
Ar1 is (i) phenyl which is substituted by 1 to 2 same or different substituents selected from the group consisting of halogen, cyano, nitro, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxyl, C1-C4-alkylthio, halo-C1-C4-alkylthio, SF5, amino, N-mono- or N,N-di-C1-C4-alkylamino, aminosulfonyl, N-mono- or N,N-di-C1-C4-alkylaminosulfonyl, N-mono- or N,N-di-halo-C1-C4-alkylaminosulfonyl, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonylamino, benzylsulfonylamino, halo-C1-C4-alkylsulfonyl, halo-C1-C4-alkylsulfinyl and halodioxolyl; or is (ii) heteroaryl selected from the group consisting of 2-, 3- or 4-pyridyl and 2- or 3-thiophenyl which is each unsubstituted or substituted by methyl, ethyl, halogen, CF3 or carboxy;
Ar2 is phenyl which is substituted by 1 to 3 same or different substituents selected from the group consisting of halogen, cyano, nitro, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkylthio, halo-C1-C4-alkylthio, SF5, amino, N-mono- or N,N-di-C1-C4-alkylamino, aminosulfonyl, N-mono- or N,N-di-C1-C4-alkylaminosulfonyl, N-mono- or N,N-di-halo-C1-C4-alkylaminosulfonyl, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonylamino, benzylsulfonylamino, halo-C1-C4-alkylsulfonyl, halo-C1-C4-alkylsulfinyl and halodioxolyl;
L1 is a bifunctional linker radical of formula
L2 is a bifunctional linker radical of formula
A and B are each independently C3-C8-hetero-cycloalkylene or C5-C10-hetero-bicycloalkylene comprising two N-atoms, respectively which is each unsubstituted or substituted by C1-C2-alkyl;
A1, A2, B1 and B2 are each independently C3-C8-hetero-cycloalkylene comprising a N-atom, respectively;
R and R′ are each independently of the other H or C1-C4-alkyl;
or a physiologically acceptable salt thereof.

### Claim 2 (depends on 1)

The compound according to claim 1, wherein R1 and R1′ are each independently of the other H, cyano, methyl or methoxy.

### Claim 3 (depends on 1)

The compound according to claim 1, wherein Z1 is N and Z2 is CR1′.

### Claim 4 (depends on 3)

The compound of formula (I) according to claim 3, wherein Q is Ar1 and Ar1 is phenyl which is substituted by 1 or 2 same or different radicals selected from the group consisting of halogen, cyano and C1-C2-haloalkyl.

### Claim 5 (depends on 3)

The compound of formula (I) according to claim 3, wherein Q is a radical —C(O)—(O)m—R2, wherein R2 is C1-C4-alkyl or C3-C6-cycloalkyl.

### Claim 6 (depends on 5)

The compound of formula (I) according to claim 5, wherein Ar2 is phenyl which is substituted by 1 or 2 same or different radicals selected from the group consisting of halogen, cyano, nitro, C1-C2-haloalkyl, C1-C2-haloalkoxy or C1-C2-haloalkylthio.

### Claim 7 (depends on 6)

The compound of formula (I) according to claim 6, wherein the linker L1 is of formula
wherein s and r are each independently an integer 1 or 2, r′ is an integer 0, 1 or 2, s′ is an integer 0, 1 or 2 and R is H or methyl.

### Claim 8 (depends on 7)

The compound of formula (I) according to claim 7, wherein the linker L2 is a radical of formula
wherein r″ is 0 or 1, s′ is an integer 1 or 2 and R′ is H or methyl.

### Claim 9 (depends on 6)

The compound of formula (I) according to claim 6, wherein L1 is a radical
and L2 is a radical

### Claim 10 (depends on 1)

The compound according to claim 1 of formula
wherein R1, R2, m, L1, L2, Z1, Z2 and Ar2 are each as defined in claim 1.

### Claim 11 (depends on 1)

The compound according to claim 1 of formula
wherein R1, Ar1, Ar2, L1, L2, Z1 and Z2 are each as defined in claim 1.

### Claim 12 (depends on 1)

The compound according to claim 1 of formula
wherein Q is 4-CF3-phenyl, 5-CF3-pyrid-2-yl, 6-CF3-pyrid-3-yl, —C(O)—O-tert.-butyl or —C(O)-cyclopropyl;
Z1 is N or CH;
Z2 is N or CH;
L1 is a radical,
L2 is a radical
R3 is CF3; and R3′ is cyano or nitro, or a physiologically acceptable salt thereof.

### Claim at position 13

13-16. (canceled)

### Claim 17

Method of controlling endoparasites, in warm-blooded animals, which comprises administering to the warm-blooded animals a veterinary effective amount of at least one compound of formula
wherein Z1 and Z2 are each independently N or CR1′;
R1 and R1′ are each independently of the other H, halogen, cyano, nitro, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C3-haloalkoxyl, C1-C4-alkylthio, halo-C1-C4-alkylthio, SF5, amino, N-mono- or N,N-di-C1-C4-alkylamino, aminosulfonyl, N-mono- or N,N-di-C1-C4-alkylaminosulfonyl, N-mono- or N,N-di-halo-C1-C4-alkylaminosulfonyl, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonylamino, halo-C1-C4-alkylsulfonyl, halo-C1-C4-alkylsulfinyl, halo-C1-C4-alkylsulfonylamino or benzylsulfonylamino;
Q is Ar1 or —C(O)—(O)m—R2;
m is 0 or 1; R2 is C1-C6-alkyl or C3-C8-cycloalkyl;
Ar1 is (i) phenyl which is substituted by 1 to 2 same or different substituents selected from the group consisting of halogen, cyano, nitro, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxyl, C1-C4-alkylthio, halo-C1-C4-alkylthio, SF5, amino, N-mono- or N,N-di-C1-C4-alkylamino, aminosulfonyl, N-mono- or N,N-di-C1-C4-alkylaminosulfonyl, N-mono- or N,N-di-halo-C1-C4-alkylaminosulfonyl, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonylamino, benzylsulfonylamino, halo-C1-C4-alkylsulfonyl, halo-C1-C4-alkylsulfinyl and halodioxolyl; or is (ii) heteroaryl selected from the group consisting of 2-, 3- or 4-pyridyl and 2- or 3-thiophenyl which is each unsubstituted or substituted by methyl, ethyl, halogen, CF3 or carboxy;
Ar2 is phenyl which is substituted by 1 to 3 same or different substituents selected from the group consisting of halogen, cyano, nitro, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkylthio, halo-C1-C4-alkylthio, SF5, amino, N-mono- or N,N-di-C1-C4-alkylamino, aminosulfonyl, N-mono- or N,N-di-C1-C4-alkylaminosulfonyl, N-mono- or N,N-di-halo-C1-C4-alkylaminosulfonyl, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonylamino, benzylsulfonylamino, halo-C1-C4-alkylsulfonyl, halo-C1-C4-alkylsulfinyl and halodioxolyl;
L1 is a bifunctional linker radical of formula
L2 is a bifunctional linker radical of formula
A and B are each independently C3-C8-hetero-cycloalkylene or C5-C10-hetero-bicycloalkylene comprising two N-atoms, respectively which is each unsubstituted or substituted by C1-C2-alkyl;
A1, A2, B1 and B2 are each independently C3-C8-hetero-cycloalkylene comprising a N-atom, respectively;
R and R′ are each independently of the other H or C1-C4-alkyl;
or a physiologically acceptable salt thereof.

### Claim 18 (depends on 17)

The method according to claim 17, wherein R1 and R1′ are each independently of the other H, cyano, methyl or methoxy.

### Claim 19 (depends on 17)

The method according to claim 17, wherein Z1 is N and Z2 is CR1′.

### Claim 20 (depends on 19)

The method according to claim 19, wherein Q is Ar1 and Ar1 is phenyl which is substituted by 1 or 2 same or different radicals selected from the group consisting of halogen, cyano and C1-C2-haloalkyl.

### Claim 21 (depends on 19)

The method according to claim 19, wherein Q is a radical —C(O)—(O)m—R2, wherein R2 is C1-C4-alkyl or C3-C6-cycloalkyl.

### Claim 22 (depends on 21)

The method according to claim 21, wherein Ar2 is phenyl which is substituted by 1 or 2 same or different radicals selected from the group consisting of halogen, cyano, nitro, C1-C2-haloalkyl, C1-C2-haloalkoxy or C1-C2-haloalkylthio.

### Claim 23 (depends on 22)

The method according to claim 22, wherein the linker L1 is of formula
wherein s and r are each independently an integer 1 or 2, r′ is an integer 0, 1 or 2, s′ is an integer 0, 1 or 2 and R is H or methyl.

### Claim 24 (depends on 23)

The method according to claim 23, wherein the linker L2 is a radical of formula
wherein r″ is 0 or 1, s′ is an integer 1 or 2 and R′ is H or methyl.

### Claim 25 (depends on 24)

The method according to claim 24, wherein L1 is a radical
and L2 is a radical

### Claim 26 (depends on 1, 25)

The compound according to claim 25 of formula
wherein R1, R2, m, L1, L2, Z1, Z2 and Ar2 are each as defined in claim 1.

### Claim 27 (depends on 1, 17)

The compound according to claim 17 of formula
wherein R1, Ar1, A2, L1, L2, Z1 and Z2 are each as defined in claim 1.

### Claim 28 (depends on 17)

The compound according to claim 17 of formula
wherein Q is 4-CF3-phenyl, 5-CF3-pyrid-2-yl, 6-CF3-pyrid-3-yl, —C(O)—O-tert.-butyl or —C(O)-cyclopropyl;
Z1 is N or CH;
Z2 is N or CH;
L1 is a radical,
L2 is a radical
R3 is CF3; and R3′ is cyano or nitro, or a physiologically acceptable salt thereof.
